loading
Olema Pharmaceuticals Inc stock is traded at $8.03, with a volume of 1.14M. It is down -0.74% in the last 24 hours and down -3.83% over the past month. Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
See More
Previous Close:
$8.09
Open:
$8.25
24h Volume:
1.14M
Relative Volume:
1.07
Market Cap:
$551.13M
Revenue:
-
Net Income/Loss:
$-96.66M
P/E Ratio:
-3.7349
EPS:
-2.15
Net Cash Flow:
$-83.73M
1W Performance:
-14.21%
1M Performance:
-3.83%
6M Performance:
+57.45%
1Y Performance:
-31.48%
1-Day Range:
Value
$7.94
$8.33
1-Week Range:
Value
$6.65
$8.48
52-Week Range:
Value
$2.86
$13.51

Olema Pharmaceuticals Inc Stock (OLMA) Company Profile

Name
Name
Olema Pharmaceuticals Inc
Name
Phone
(415) 651-3316
Name
Address
780 BRANNAN STREET, SAN FRANCISCO
Name
Employee
117
Name
Twitter
Name
Next Earnings Date
2025-03-18
Name
Latest SEC Filings
Name
OLMA's Discussions on Twitter

Compare OLMA with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
OLMA
Olema Pharmaceuticals Inc
8.03 555.25M 0 -96.66M -83.73M -2.15
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
421.39 108.36B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
463.43 60.82B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
577.95 61.02B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
817.32 50.01B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
310.81 34.05B 4.56B -176.77M 225.30M -1.7177

Olema Pharmaceuticals Inc Stock (OLMA) Upgrades & Downgrades

Date Action Analyst Rating Change
Oct-08-25 Initiated Guggenheim Buy
Aug-12-25 Reiterated Citigroup Buy
Apr-02-24 Initiated Goldman Buy
Jan-30-24 Initiated Citigroup Buy
Jul-21-23 Initiated Oppenheimer Outperform
May-05-23 Initiated CapitalOne Overweight
Feb-22-23 Initiated Credit Suisse Outperform
Jul-06-22 Resumed Canaccord Genuity Buy
Jun-09-22 Upgrade H.C. Wainwright Neutral → Buy
Feb-28-22 Initiated H.C. Wainwright Neutral
Dec-07-21 Resumed Cowen Outperform
Dec-14-20 Initiated Canaccord Genuity Buy
Dec-14-20 Initiated Cowen Outperform
Dec-14-20 Initiated JP Morgan Overweight
Dec-14-20 Initiated Jefferies Buy
View All

Olema Pharmaceuticals Inc Stock (OLMA) Latest News

pulisher
04:34 AM

Olema Pharmaceuticals (NASDAQ:OLMA) Receives Sell (D-) Rating from Weiss Ratings - MarketBeat

04:34 AM
pulisher
04:27 AM

Olema Pharmaceuticals Inc. stock momentum explained2025 Fundamental Recap & Fast Gain Swing Trade Alerts - newser.com

04:27 AM
pulisher
03:34 AM

Will Olema Pharmaceuticals Inc. stock rally after Fed decisionsQuarterly Earnings Summary & Target Return Focused Stock Picks - newser.com

03:34 AM
pulisher
02:23 AM

Has Olema Pharmaceuticals Inc. found a price floor2025 Stock Rankings & Daily Stock Momentum Reports - newser.com

02:23 AM
pulisher
01:21 AM

Will Olema Pharmaceuticals Inc. continue its uptrend2025 Investor Takeaways & Technical Buy Zone Confirmation - newser.com

01:21 AM
pulisher
12:13 PM

How sustainable is Olema Pharmaceuticals Inc. stock dividend payout2025 Trading Recap & Daily Profit Maximizing Tips - newser.com

12:13 PM
pulisher
Oct 25, 2025

Olema Pharmaceuticals Inc Stock Analysis and ForecastSector ETF Performance & Rapid Portfolio Trading - earlytimes.in

Oct 25, 2025
pulisher
Oct 25, 2025

Why Olema Pharmaceuticals Inc. stock is in analyst buy zone2025 Breakouts & Breakdowns & Risk Managed Investment Strategies - newser.com

Oct 25, 2025
pulisher
Oct 25, 2025

Can Olema Pharmaceuticals Inc. stock double in next 5 yearsMarket Volume Summary & Free Technical Pattern Based Buy Signals - newser.com

Oct 25, 2025
pulisher
Oct 23, 2025

Setup Watch: Will Olema Pharmaceuticals Inc. stock rally after Fed decisions2025 Stock Rankings & Low Risk High Reward Trade Ideas - nchmf.gov.vn

Oct 23, 2025
pulisher
Oct 23, 2025

Olema Pharmaceuticals (OLMA) Stock Analysis: A 197.62% Potential Upside in the Biotech Sector - DirectorsTalk Interviews

Oct 23, 2025
pulisher
Oct 22, 2025

Using flow based indicators on Olema Pharmaceuticals Inc.July 2025 Volume & Smart Allocation Stock Reports - newser.com

Oct 22, 2025
pulisher
Oct 21, 2025

Visual trend scoring systems applied to Olema Pharmaceuticals Inc.2025 Dividend Review & Long-Term Growth Portfolio Plans - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Olema Pharmaceuticals (NASDAQ:OLMA) Shares Up 7.3%What's Next? - MarketBeat

Oct 21, 2025
pulisher
Oct 21, 2025

Olema Pharmaceuticals: Tapping The Brakes (Rating Downgrade) (NASDAQ:OLMA) - Seeking Alpha

Oct 21, 2025
pulisher
Oct 20, 2025

Olema Pharmaceuticals Reports Positive Phase 1b/2 Trial Results - TipRanks

Oct 20, 2025
pulisher
Oct 20, 2025

Olema Pharmaceuticals, Inc. Presents New Data from Phase 1b/2 Trial of Palazestrant - TradingView

Oct 20, 2025
pulisher
Oct 20, 2025

Olema Pharmaceuticals (NASDAQ:OLMA) Shares Gap DownHere's Why - MarketBeat

Oct 20, 2025
pulisher
Oct 20, 2025

Olema Pharmaceuticals Shares Fall After Roche's Breast Cancer Data Weighs on Sector - MarketScreener

Oct 20, 2025
pulisher
Oct 20, 2025

Olema Pharmaceuticals (OLMA) Shares Drop Following Trial Data - GuruFocus

Oct 20, 2025

Olema Pharmaceuticals Inc Stock (OLMA) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$37.26
price up icon 1.11%
$91.28
price up icon 2.21%
$29.89
price up icon 0.07%
$105.66
price up icon 0.87%
$159.66
price down icon 0.29%
biotechnology ONC
$310.81
price up icon 0.25%
Cap:     |  Volume (24h):